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lines informing the use of UDM, there appears to be a general consensus among
practitioners that utilize UDMon:which patients tomonitor, how often tomonitor,
and which substances are most important to detect.
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OBJECTIVES: To estimate the predictive accuracy of methods used to identify pa-
tients receiving peritoneal dialysis (PD) and hemodialysis (HD) in healthcare ad-
ministrative data. METHODS: The study population consisted of all persons aged
18-63 years with evidence of end-stage renal disease (ESRD) who were members of
a large US urban health maintenance organization between January 1, 2005 and
December 31, 2008 (“study period”). Using healthcare administrative data, we iden-
tified all those with any dialysis-related procedure or diagnosis codes; the date of
each patient’s first such encounterwas then designated as the “anchor date”. Using
only codes in healthcare administrative data within 30 days of anchor date, we
then designated each patient as either PD or HD. Medical records were then re-
viewed by trained abstractors using a 180-day window around each patient’s an-
chor date to ascertain positive predictive value (PPV) of procedure and diagnosis
codes in administrative data for receipt of PD and HD. RESULTS: We identified a
total of 233 patients with ESRD and one or more healthcare encounters with dial-
ysis-related procedure and diagnosis codes. Of these, 43 had codes suggesting
receipt of PD, and 173 had codes suggesting receipt of HD; dialysis modality could
not be determined for the remaining 17 patients. PPV of PD-related codes for iden-
tifying patients receiving PD within 30 days of anchor date was 34.9%; it was 67.4%
within both 90 days and 180 days of anchor date. PPV of HD-related codes for
identifying patients receiving HD within 30 days of anchor date was 86.7%; it was
90.8% within 90 days of anchor date, and 93.1% within 180 days of this date.
CONCLUSIONS: While HD-related procedure and diagnosis codes appear to have
relatively high predictive accuracy for identifying patients receiving HD, predictive
accuracy of the codes used to identify patients receiving PD is much lower.
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OBJECTIVES: Observational health care data are often used to study patient popu-
lations and outcomes of interest. Electronic Health Record (EHR) data provide a
granular and longitudinal look at patient care; however, much information is bur-
ied within the narrative text of clinical notes and is not typically available for
research. Diagnosis and procedure codes pose two difficulties when identifying
central venous catheter (CVC) episodes: 1) they are underused and 2) they are
associated with the encounter and not the actual CVC event. METHODS: We ap-
plied advanced healthcare data analyticswith natural language processing (NLP) to
extractmeaningful information about patient care from text clinical information in
the Veteran Affairs nationwide EHR database. The NLP was designed to help iden-
tify and characterize CVC episodes for patients with an inpatient encounter. Pa-
tients were characterized as having (a) a billing code for catheter insertion and (b)
having had a chest x-ray during an inpatient encounter where the presence of a
CVC was identified by NLP. RESULTS: 1.2M patients with an inpatient encounter
were found in the VA between January 1, 2006-December 31, 2010. Of them, 54,676
patients were identified as having at least one inpatient CVC episode using billing
codes. 119,768 additional patients were preliminarily identified via NLP, resulting
in a total of 174,444 CVC patients. CONCLUSIONS: Fifteen percent of inpatients had
a CVC placed and 69% of CVC patients were only identified via NLP. These rates are
consistentwith previously published literature. Thiswork shows thatNLP provides
an effective way to leverage rich observational data. We will use this to study
health outcomes in relation to the catheter placement and related interventions.
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OBJECTIVES: Probabilistic sensitivity analysis (PSA) repeatedly runs a simulation
model with randomly selected inputs to characterize the plausible distributions of
projected outcomes. In cost-effectiveness analysis, PSA results are conventionally
displayed as incremental cost-effectiveness scatter plots or cost-effectiveness ac-
ceptability curves. We explored patient-relevant health outcomes other than
QALYs and investigated approaches for displaying probabilistically generated val-
ues, using the case of catheter-based renal denervation (RDN) for resistant
hypertension. METHODS: A Markov model with 54 input distributions simulated
the impact of RDN on stroke, myocardial infarction (MI), coronary heart disease
(CHD), heart failure (HF), end-stage renal disease (ESRD), cardiovascular (CV) and
all-cause death based on the Symplicity HTN-2 RCT and the literature. We report
medians and 95% credible intervals (95% CI), defined as containing 95% of all sim-
ulation results, of 10-year relative risk reductions. One-sample t-tests and ANOVA
were used to compare posterior distributions. Additional analyses evaluated alter-
native time horizons, with values ranging from one year to lifetime. RESULTS:
Relative risk reductions over ten years (95% CI) were: stroke 31.4% (23.1; 36.0%), MI
30.0% (8.9; 38.1%), CHD 22.2% (9.0; 29.4%), HF 13.9% (11.0; 21.7%), ESRD 30.7% (28.8;
34.5%), CV death 30.3% (12.6; 35.7%), and all-cause death 14.4% (4.1; 20.1%). All
clinical outcomes were significantly different from 0% and between each other
(p0.0001). Distribution dotplots, cumulative hazard curves, and survival curves
with 95% credibility intervals were developed as graphic representations of prob-
abilistic results. CONCLUSIONS:Whilemodel-based projections suggest that cath-
eter-based renal denervation leads to clinically and statistically significant event
reductions across clinical outcomes, considerable differences exist between the
distributions of individual reductions. Graphic, probabilistic representation of pa-
tient-relevant endpoints may facilitate a deeper understanding of uncertainty as-
sociated with the long-term clinical effectiveness of new therapies. In addition to
informing clinicians and payers, the proposed conceptual approach could also
contribute to patient education and shared decision making.
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OBJECTIVES: The conventional incremental cost-effectiveness ratio (ICER) and
cost-per-expected life in patients undergoing prolonged mechanical ventilation
(PMV), stratified by different underlying diseases, were determined. METHODS: A
nationwide sample of 50,481 patients who had received continualmechanical ven-
tilation for more than 21 days was collected during 1997-2007. After stratifying the
patients according to specific diagnoses, a latent class analysis (LCA) was per-
formed to categorize PMV patients with multiple co-morbidities into several ho-
mogeneous groups. The survival functions were estimated for individual groups
using the Kaplan-Meier method and extrapolated to 300 months through a semi-
parametricmethod. The survival functions were adjusted with a utility valuemea-
sured by EQ-5D from a convenient sample of 142 PMV patients to estimate the
quality-adjusted life expectancies (QALE). The lifetime expenditures paid by Na-
tional Health Insurance (NHI) were estimated bymultiplying the average spending
with the survival probability for different duration-to-dates and summed up for
different groups. RESULTS: The results showed that PMV therapy costs over
58,000 USD (U.S.dollars) per QALY for almost all patients with poor cognition.
For patients with partial cognition, PMV therapy costs less than 33,000 USD per
QALY for those with cancer, liver cirrhosis, intracranial or spinal cord injuries,
or multiple co-morbidities who are less than 65 years of age; it costs about
52,000-63,400 USD per QALY for those with end stage renal disease, degenera-
tive neurological diseases, or multiple co-morbidities over age 85. All costs-per-
expected life were below 38,000 USD except for those with a longer life expec-
tancy or QALE. CONCLUSIONS: The conventional ICER for PMV varies greatly
depending on the different underlying causes and co-morbidities. The mainte-
nance treatment for PMV patients with poor cognition is the least cost-effective.
The indicator of cost-per-expected life could be considered to improve fairness
in resource allocation.
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OBJECTIVES: Little is known about the acquisition of Clostridium difficile infection
(CDI) and whether it represents hospital- or community-acquired infection. The
objective of this study is to test the feasibility and value of using national hospital
admissions data from Hospital Episode Statistics to examine trends in CDI in
England.METHODS: Hospital Episode Statistics from the period 1997/98 to 2009/10
were used. Time trends were analysed using two different denominators of hospi-
tal activity: total admissions and total bed-days. We explored the impact of so-
ciodemographic factors, comorbidity and healthcare pathways on the risk of CDI.
RESULTS: CDI rates per admission and per bed-days increased from 1997/98 to
2006/07, then decreased significantly by 50% from 2008/9 and 2009/10. This pat-
tern was similar for patients regardless of probable source of infection but the
proportion of probable community-acquired CDI cases rose steadily from 7% in
1997/98 to 13% in 2009/10. CDI rates were higher among older patients (odds ratio:
65 years, 10.9), those with more comorbid conditions (odds ratio for Charlson
index: 5, 5.6), and among patients admitted as an emergency compared with
elective admissions, but no relationship was found with deprivation score.
CONCLUSIONS: Our findings support not only the falling trend in CDI found in the
national mandatory surveillance scheme from the Health Protection Agency, but a
growing proportion of CDI presenting on admission with no evidence of prior hos-
pital exposure in the previous 90 days. We suggest that these may be community-
acquired CDI cases.
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